AZN — AstraZeneca plc
In 2026 Q2, 7 of the 140 tracked hedge funds reported a position in AstraZeneca plc (AZN), worth $373.44M combined. Over the quarter 5 opened or added, 1 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Polar Capital | $236.56M | 0.67% | NEW |
| VanEck | $104.49M | 0.06% | +102.2% |
| Quadrature | $29.87M | 0.26% | +2249.5% |
| IMC | $1.47M | 0.01% | NEW |
| Persistent | $769.48K | 0.24% | +228.3% |
| Chapin Davis | $257.24K | 0.05% | -26% |
| Pingora | $23.70K | 0.01% | NO CHANGE |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.